Skip to main content
Dan Barouch, MD, Infectious Disease, Boston, MA

DanHBarouchMD

Infectious Disease • Boston, MA

Professor, Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School

Join to view full profile

Dr. Barouch is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Barouch's full profile

Already have an account?

  • Office

    330 Brookline Ave
    Research East 113 Beth Israel Deaconess Hospital
    Boston, MA 02215
    Phone+1 617-667-4434
    Fax+1 617-667-8210

Education & Training

  • Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical School
    Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Infectious Disease, 2001 - 2005
  • Harvard Medical School
    Harvard Medical SchoolClass of 2000

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2001 - 2026
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Infectious Disease
    American Board of Internal Medicine Infectious Disease

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine  
    Jerald Sadoff, Kathryn E Stephenson, Dan H Barouch, Macaya Douoguih, The New England Journal of Medicine

Lectures

  • 11th Vaccines Research and Development: All Things Considered Conference 
    Global Technology Community (GTC), Boston, Massachusetts - 7/8/2013
  • Publisher Correction: Antibody and TLR7 Agonist Delay Viral Rebound in SHIV-Infected Monkeys 
    Beth Israel Deaconess Hospital - Needham , Harvard Medical School ,Department Of Continuing Educatio - 5/30/2013

Press Mentions

  • ‘Patients Are Very Sick’: Flu Cases Peaking in Massachusetts, Rest of Country
    ‘Patients Are Very Sick’: Flu Cases Peaking in Massachusetts, Rest of CountryFebruary 26th, 2025
  • CDC Investigating Hospitalizations of Five People Who Recently Received Chikungunya Vaccine
    CDC Investigating Hospitalizations of Five People Who Recently Received Chikungunya VaccineFebruary 26th, 2025
  • Mass. (Un)vaccination: A New Wave of Vaccine Skepticism Threatens Readiness for the Next Pandemic
    Mass. (Un)vaccination: A New Wave of Vaccine Skepticism Threatens Readiness for the Next PandemicFebruary 18th, 2025
  • Join now to see all

Grant Support

  • Multi-Omics Analysis of Broadly Neutralizing Antibodies and Therapeutic VaccinationBETH ISRAEL DEACONESS MEDICAL CENTER2023–2028
  • HIV Vaccines Clinical Trials Network Leadership and Operations CenterFRED HUTCHINSON CANCER CENTER2006–2027
  • I4C 2.0: Immunotherapy for CureBETH ISRAEL DEACONESS MEDICAL CENTER2021–2026
  • Ad26 Based Therapeutic Vaccines for HIVBETH ISRAEL DEACONESS MEDICAL CENTER2020–2026
  • Immunologic Signatures of SARS-CoV-2 Vaccination and DiseaseBETH ISRAEL DEACONESS MEDICAL CENTER2020–2025
  • Immunologic Signatures of SARS-CoV-2 Vaccination and DiseaseBETH ISRAEL DEACONESS MEDICAL CENTER2020–2025
  • Immunologic Signatures of SARS-CoV-2 Vaccination and DiseaseBETH ISRAEL DEACONESS MEDICAL CENTER2020–2025
  • Single-Cell Analysis of the HIV/SIV ReservoirBETH ISRAEL DEACONESS MEDICAL CENTER2020–2025
  • Development of Ad26/Env Vaccines for HIVBETH ISRAEL DEACONESS MEDICAL CENTER2018–2025
  • Consortium For AIDS Vaccine Research In Nonhuman PrimatesNational Institute Of Allergy And Infectious Diseases2011
  • AdministrativeNational Institute Of Allergy And Infectious Diseases2011
  • Adenovirus And Poxvirus Mediated Protection Against Mucosal SIV InfectionNational Institute Of Allergy And Infectious Diseases2011
  • Metagenomics Of Enteric Disease In Siv-Infected And Uninfected MacaquesNational Center For Research Resources2011
  • Impact Of HIV Envelope Conformation On ImmunogenicityNational Institute Of Allergy And Infectious Diseases2009–2011
  • Preclinical Evaluation Of Novel Adenovirus Prime-Boost HIV-1 VaccineNational Institute Of Allergy And Infectious Diseases2008–2011
  • Novel Heterologous Adenovirus Prime-Boost HIV-1 VaccineNational Institute Of Allergy And Infectious Diseases2008–2011
  • Administrative CoreNational Institute Of Allergy And Infectious Diseases2008–2011
  • Novel Recombinant Adenovirus Vaccine Vectors For HIV/SIV In Rhesus MonkeysNational Center For Research Resources2005–2011
  • Novel Adenovirus Vaccine Vectors For HIV/SIVNational Institute Of Allergy And Infectious Diseases2006–2010
  • Preclinical Evaluation Of Novel Adenovirus VectorsNational Institute Of Allergy And Infectious Diseases2005–2009
  • Novel Adenovirus Vector-Based Vaccines For HIV-1National Institute Of Allergy And Infectious Diseases2005–2009
  • Augmentation Of DNA Vaccine-Elicited Immunity To HIV/SIVNational Institute Of Allergy And Infectious Diseases2004–2008
  • AdministrativeNational Institute Of Allergy And Infectious Diseases2005
  • Chimeric Adenovirus Vaccine Vectors For HIV/SIVNational Institute Of Allergy And Infectious Diseases2004–2005
  • Cytokine-Augmented DNA Vaccine-Elicited Immunity To HIVNational Institute Of Allergy And Infectious Diseases2002–2005

Dr. Dan Barouch, Dr. Dan Barouch, MD, Dr. D Barouch, Dr. Dan H Barouch